Asia
JapanModerna and Merck report positive results from mRNA cancer vaccine trial
Moderna and Merck announce positive trial results for an mRNA cancer vaccine, showing a significant reduction in death and recurrence.
Background
mRNA technology, notably used in COVID-19 vaccines, has been a focus of medical research for its potential in treating various diseases, including cancer. This development represents a significant area of ongoing scientific exploration by pharmaceutical companies.
Quorum · collective opinions
Japanese Cancer Vaccine Trial Results
First report 7h agoLast update 4h ago2 takes▲ 1 1
positive vaccine resultspositiveShow 1 post
started 4h ago•Last update 4h ago
Reports on the success of an mRNA cancer vaccine in clinical trials, indicating a substantial decrease in mortality and disease recurrence.
japanese cancer treatment claimneutralShow 1 post
started 7h ago•Last update 7h ago
Claims that Japanese scientists have found a definitive cure for cancer using a method that induces cancer cells to self-destruct.
iWitness comments
No comments yet — be the first to weigh in.